Mahmoud M. Kamel

1.1k total citations
91 papers, 798 citations indexed

About

Mahmoud M. Kamel is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Mahmoud M. Kamel has authored 91 papers receiving a total of 798 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 22 papers in Cancer Research and 19 papers in Epidemiology. Recurrent topics in Mahmoud M. Kamel's work include MicroRNA in disease regulation (9 papers), Respiratory viral infections research (8 papers) and Acute Myeloid Leukemia Research (7 papers). Mahmoud M. Kamel is often cited by papers focused on MicroRNA in disease regulation (9 papers), Respiratory viral infections research (8 papers) and Acute Myeloid Leukemia Research (7 papers). Mahmoud M. Kamel collaborates with scholars based in Egypt, Saudi Arabia and United States. Mahmoud M. Kamel's co-authors include Ahmed S. Abdel‐Moneim, Abdel‐Rahman N. Zekri, Abeer A. Bahnassy, Zeinab Hassan, Mohamed M. Hafez, Alaa Elhaddad, Azza M. Kamel, Eman A. Elghoroury, Ahmed Samir Abdelhafiz and Shady Adnan Awad and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Mahmoud M. Kamel

80 papers receiving 790 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mahmoud M. Kamel Egypt 17 195 149 133 122 122 91 798
Ahmad Gharehbaghian Iran 16 302 1.5× 272 1.8× 130 1.0× 108 0.9× 115 0.9× 81 1.0k
Lesley M. Chapman United States 5 249 1.3× 93 0.6× 117 0.9× 165 1.4× 326 2.7× 5 972
Uroš Potočnik Slovenia 17 266 1.4× 156 1.0× 124 0.9× 237 1.9× 51 0.4× 87 1.0k
Tae Sung Park South Korea 18 334 1.7× 100 0.7× 65 0.5× 84 0.7× 368 3.0× 90 914
Sizhou Feng China 18 212 1.1× 186 1.2× 73 0.5× 296 2.4× 377 3.1× 160 1.1k
Masashi Matsuyama Japan 14 153 0.8× 150 1.0× 62 0.5× 86 0.7× 37 0.3× 42 673
Benoît Gilbert Switzerland 9 441 2.3× 122 0.8× 42 0.3× 97 0.8× 84 0.7× 26 1.1k
Xiaolin Yin China 17 341 1.7× 113 0.8× 193 1.5× 114 0.9× 161 1.3× 64 892
Meganathan Kannan India 20 181 0.9× 115 0.8× 89 0.7× 51 0.4× 468 3.8× 76 1.0k
Tao Ying China 19 344 1.8× 146 1.0× 120 0.9× 134 1.1× 177 1.5× 88 1.2k

Countries citing papers authored by Mahmoud M. Kamel

Since Specialization
Citations

This map shows the geographic impact of Mahmoud M. Kamel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahmoud M. Kamel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahmoud M. Kamel more than expected).

Fields of papers citing papers by Mahmoud M. Kamel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mahmoud M. Kamel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahmoud M. Kamel. The network helps show where Mahmoud M. Kamel may publish in the future.

Co-authorship network of co-authors of Mahmoud M. Kamel

This figure shows the co-authorship network connecting the top 25 collaborators of Mahmoud M. Kamel. A scholar is included among the top collaborators of Mahmoud M. Kamel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mahmoud M. Kamel. Mahmoud M. Kamel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hamdy, Rana, et al.. (2024). Identification of Lower Respiratory Tract Pathogens in Cancer Patients: Insights into Fatal Outcomes. Microorganisms. 12(8). 1686–1686.
2.
Kamel, Mahmoud M., et al.. (2024). CYP2C8 rs11572080 and CYP3A4 rs2740574 risk genotypes in paclitaxel-treated premenopausal breast cancer patients. Scientific Reports. 14(1). 7922–7922. 4 indexed citations
3.
Kamel, Mahmoud M., et al.. (2024). Prognostic impact of matrix metalloproteinase 2 (MMP-2) and matrix metalloproteinase 9 (MMP-9) in Egyptian breast cancer patients. International Journal of Immunopathology and Pharmacology. 38. 1210525007–1210525007. 3 indexed citations
5.
Abdel‐Latif, Mahmoud, Mahmoud M. Kamel, Ibrahim M. Alhazza, et al.. (2024). Investigating the Tumor-Suppressive, Antioxidant Effects and Molecular Binding Affinity of Quercetin-Loaded Selenium Nanoparticles in Breast Cancer Cells. BioNanoScience. 15(1). 3 indexed citations
6.
Safwat, Gehan, et al.. (2023). Associations Between Serum Soluble Toll-like Receptors 4 and 9 and Breast Cancer in Egyptian Patients. Cancer Control. 30. 2915622803–2915622803. 4 indexed citations
7.
Kamel, Mahmoud M., et al.. (2023). Changes in breast cancer staging trends among Egyptian women after COVID-19: A retrospective single-center study. International Journal of Immunopathology and Pharmacology. 37. 1200372931–1200372931. 4 indexed citations
8.
Elbahnasawy, Mostafa A., et al.. (2023). The impact of hepatitis B virus and hepatitis C virus infections in patients with Hodgkin's and non-Hodgkin’s lymphoma. International Journal of Immunopathology and Pharmacology. 37. 1200427438–1200427438. 3 indexed citations
10.
Azmy, Osama, et al.. (2022). Metabolic syndrome as independent risk factor among sample of Egyptian women with breast cancer. SHILAP Revista de lepidopterología. 46(1).
11.
Salem, Salem, et al.. (2021). Fluoropyrimdine therapy induced alterations in interleukins expression in colorectal cancer patients. International Journal of Immunopathology and Pharmacology. 35. 3938478924–3938478924. 1 indexed citations
12.
Eid, Maha M., et al.. (2020). Altered Expression of MicroRNAs in the Bone Marrow of Multiple Myeloma Patients and their Relationship to Cytogenetic Aberrations. Current Pharmaceutical Biotechnology. 21(13). 1394–1401. 3 indexed citations
13.
Awad, Shady Adnan, Matti Kankainen, Teija Ojala, et al.. (2020). Mutation accumulation in cancer genes relates to nonoptimal outcome in chronic myeloid leukemia. Blood Advances. 4(3). 546–559. 38 indexed citations
15.
Elghoroury, Eman A., et al.. (2017). Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer. Clinical Breast Cancer. 18(4). e721–e726. 59 indexed citations
16.
Awad, Shady Adnan, Matti Kankainen, Samuli Eldfors, et al.. (2017). Identification of Progression-Associated Mutations in Chronic Myeloid Leukemia (CML) By Comparative Genomic Analysis. Blood. 130. 250–250. 1 indexed citations
17.
Ibrahim, Iman, et al.. (2016). Circulating DNA in Egyptian Women with Breast Cancer.. PubMed. 17(6). 2989–93. 9 indexed citations
18.
Abdel‐Moneim, Ahmed S., et al.. (2015). A novel primer set for improved direct gene sequencing of human bocavirus genotype-1 from clinical samples. Journal of Virological Methods. 228. 108–113. 17 indexed citations
19.
Kamel, Mahmoud M., et al.. (2015). Prevalence of the frequency of JAK2 (V617F) mutation in different myeloproliferative disorders in Egyptian patients.. PubMed. 8(9). 11555–9. 6 indexed citations
20.
Kamel, Mahmoud M., et al.. (2011). Biological monitoring of the ethylene oxide gas effects on medical utilities sterilization exposed staff. Eastern Journal Of Medicine. 16(1). 44–52. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026